RADX Stock

Profile

Full Name:

Radiopharm Theranostics Limited

Sector:

Healthcare

Industry:

Biotechnology

Country:

Australia

IPO:

Indexes:

Not included

Website:

http://www.radiopharmtheranostics.com

Description:

A biotechnology company focused on developing and commercializing radiopharmaceuticals for the diagnosis and treatment of cancer and other diseases.

Key Details

Price

$4.81

Market Cap

$11.23 B(Large cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$196.20 K(-0.25% YoY)

Annual EPS

-$0.08(-13.21% YoY)

PE Ratio

-

Annual ROE

-129.75%

Annual Debt To Equity

0.00

Beta

-2.07

Events Calendar

Earnings

Next earnings date:

N/A

Recent quarterly earnings:

N/A

Recent annual earnings:

N/A
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

No data about analysts updates

Screeners with RADX included

Large cap stocks
NASDAQ earnings calendar
Stocks below SMA 200
Stocks with low beta
High Altman Z score stocks

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$4.81
RADX price is $4.81

Price YTD Change

+7.13%
RADX price is up +7.13% since January 1st

Price All-time High

$18.90
RADX price is currently -74.55% below its historical high of $18.90

Market Cap

$11.23 B
RADX market capitalization is $11.23 billion

Beta

-2.07
RADX beta is -2.07

200-day SMA

$5.87
RADX price is currently -18.03% below its 200-day simple moving average

14-day RSI

35.59
RADX 14-day relative strength index is 35.59

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Revenue 3-Year Change

+2965.62%
RADX annual revenue is up +2965.62% over the past 3 years

Annual Revenue Estimate

$21.27 M
RADX annual revenue is currently -99.08% lower than the consensus analysts' forecast

Annual Net Income 3-Year Change

-42.89%
RADX annual net profit is down -42.89% over the past 3 years

Annual EPS 3-Year Change

+26.53%
RADX annual earnings per share is up +26.53% over the past 3 years

Annual Gross Profit

$196.20 K
RADX annual gross profit is $196.20 thousand

Annual Operating Profit

-$24.01 M
RADX annual operaing income is -$24.01 million

Annual Operating Profit 3-Year Change

-66.24%
RADX annual operaing income is down -66.24% over the past 3 years

Efficiency

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Operating Margin Sector Rank

6.56%
RADX annual operating profit margin is higher than 6.56% of companies in Healthcare sector

Annual Net Margin Sector Rank

5.3%
RADX annual net profit margin is higher than 5.3% of companies in Healthcare sector

Annual ROE

-129.75%
RADX annual return on equity is -129.75%

Annual ROA

-64.31%
RADX annual return on assets is -64.31%

Annual EBIT

-$30.95 M
RADX annual earnings before interest & taxes is -$30.95 million

Annual EBITDA

-$28.90 M
RADX annual earnings before interest, taxes, depreciation & amortization is -$28.90 million

Annual Interest Coverage Ratio

-73.43
RADX annual interest coverage ratio is -73.43

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PB Ratio Sector Rank

99.76%
RADX price to book ratio is higher than 99.76% of companies in Healthcare sector

Enterprise Value

$11.21 B
RADX enterprise value is $11.21 billion

Liquidity

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Debt To Equity Sector Rank

48.53%
RADX annual debt to equity ratio is higher than 48.53% of companies in Healthcare sector

Annual Current Ratio

1.30
RADX annual current ratio is 1.30

Annual Current Ratio Sector Rank

22.13%
RADX annual current ratio is higher than 22.13% of companies in Healthcare sector

Annual Total Assets

$48.15 M
RADX annual total assets is $48.15 million

Annual Current Assets

$15.27 M
RADX annual total current assets is $15.27 million

Annual Total Liabilities

$29.87 M
RADX annual total liabilities is $29.87 million

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual CFF 3-Year Change

-58.51%
RADX annual cash flow from financing activities is down -58.51% over the past 3 years

Institutional Ownership

Similar stocks

PCVX logo
Vaxcyte (PCVX)
SRPT logo
Sarepta Therapeutics (SRPT)
SNN logo
Smith & Nephew (SNN)
COR logo
Cencora (COR)
CTLT logo
Catalent (CTLT)
DOCS logo
Doximity (DOCS)
RDY logo
Dr Reddys Laboratories Limited (RDY)
BMRN logo
BioMarin Pharmaceutical (BMRN)
MEDP logo
Medpace Holdings (MEDP)

FAQ

  • What is the primary business of Radiopharm Theranostics Limited?
  • What is the ticker symbol for Radiopharm Theranostics Limited?
  • Does Radiopharm Theranostics Limited pay dividends?
  • What sector is Radiopharm Theranostics Limited in?
  • What industry is Radiopharm Theranostics Limited in?
  • What country is Radiopharm Theranostics Limited based in?
  • Is Radiopharm Theranostics Limited in the S&P 500?
  • Is Radiopharm Theranostics Limited in the NASDAQ 100?
  • Is Radiopharm Theranostics Limited in the Dow Jones?
  • When does Radiopharm Theranostics Limited report earnings?

What is the primary business of Radiopharm Theranostics Limited?

A biotechnology company focused on developing and commercializing radiopharmaceuticals for the diagnosis and treatment of cancer and other diseases.

What is the ticker symbol for Radiopharm Theranostics Limited?

The ticker symbol for Radiopharm Theranostics Limited is NASDAQ:RADX

Does Radiopharm Theranostics Limited pay dividends?

No, Radiopharm Theranostics Limited does not pay dividends

What sector is Radiopharm Theranostics Limited in?

Radiopharm Theranostics Limited is in the Healthcare sector

What industry is Radiopharm Theranostics Limited in?

Radiopharm Theranostics Limited is in the Biotechnology industry

What country is Radiopharm Theranostics Limited based in?

Radiopharm Theranostics Limited is headquartered in Australia

Is Radiopharm Theranostics Limited in the S&P 500?

No, Radiopharm Theranostics Limited is not included in the S&P 500 index

Is Radiopharm Theranostics Limited in the NASDAQ 100?

No, Radiopharm Theranostics Limited is not included in the NASDAQ 100 index

Is Radiopharm Theranostics Limited in the Dow Jones?

No, Radiopharm Theranostics Limited is not included in the Dow Jones index

When does Radiopharm Theranostics Limited report earnings?

The date for Radiopharm Theranostics Limited's next earnings report has not been announced yet